Balasa Dinverno & Foltz LLC Horizon Therapeutics Public LTD CO Transaction History
Balasa Dinverno & Foltz LLC
- $1.58 Billion
- Q3 2022
A detailed history of Balasa Dinverno & Foltz LLC transactions in Horizon Therapeutics Public LTD CO stock. As of the latest transaction made, Balasa Dinverno & Foltz LLC holds 5,814 shares of HZNP stock, worth $0. This represents 0.02% of its overall portfolio holdings.
Number of Shares
5,814
Previous 8,417
30.93%
Holding current value
$0
Previous $671,000
46.35%
% of portfolio
0.02%
Previous 0.04%
Shares
9 transactions
Others Institutions Holding HZNP
# of Institutions
38Shares Held
2.07MCall Options Held
0Put Options Held
20K-
Pictet Asset Management Sa Geneva 73, V8735KShares$00.09% of portfolio
-
Rothschild & CO Asset Management Us Inc. New York, NY404KShares$00.7% of portfolio
-
Jefferies Group LLC New York, NY237KShares$00.14% of portfolio
-
Ergoteles LLC New York, NY122KShares$020.67% of portfolio
-
Regent Investment Management LLC101KShares$03.09% of portfolio
About Horizon Therapeutics Public Ltd Co
- Ticker HZNP
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 230,384,000
- Description
- Horizon Therapeutics Public Limited Company, a biotechnology company, focuses on the discovery, development, and commercialization of medicines that address critical needs for people impacted by rare, autoimmune, and severe inflammatory diseases. The company operates in two segments, Orphan and Inflammation. Its portfolio comprises 12 medicines ...